Nodenza Venture Partners to attend LSX London 2025
- Article
- Oct 16, 2025
- 1 Min Read
Written By Nodenza
London, UK – November 17, 2025 – Nodenza Venture Partners (“Nodenza”) will participate in the LSX Investival Showcase during London Life Sciences Week.
The firm will meet with healthcare innovators, global investors, and strategic partners aligned with its focus on clinical proof-of-concept and product launch life sciences assets.
Nodenza’s engagement will center on sourcing differentiated opportunities and strengthening institutional relationships across the European life sciences ecosystem.
Event Information: LSX London / Investival Showcase
Contacts
Nodenza Venture Partner
Notes For Editors
About Nodenza Venture Partners
Nodenza Venture Partners provides investment and operational support to clinical proof-of-concept and product launch biotech and medtech companies seeking to bring exceptional benefits to patients. Our bi-modal investment strategy combines early-stage opportunities – advancing new treatment modalities through active IND to phase 2 – with commercial targets supporting their transition from scientific to commercial companies delivering strong upside potential. Established by a team of experienced life sciences entrepreneurs, founders and leaders, our approach leverages Nodenza’s extensive expertise in the creation and growth of new companies, as well as late-stage product development and launch.
